Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPAR agonists in obese men: monocyte/macrophage function, vascular inflammation, and insulin resistance
2006-004296-35Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fenofibrate and pioglitazone in obesity and insulin resistance (IR) (3 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoints: Peripheral monocyte inflammatory activation, Adipose monocyte inflammatory activation and 1 more. Started Sep 2007; status: completed.
02
Drugs
fenofibratepioglitazone
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on 2006-004296-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004296-35.